Novartis CEO Upbeat In The Midst Of Market Challenges
USA Today: Novartis CEO Upbeat On Company, Health Care
One of the worst flu seasons in decades is finally showing signs of abating. But health care companies and individuals are still absorbing higher costs as the president's health care legislation begins to take effect. The fees and taxes related to Obamacare take effect this year, while the rest will be implemented in the coming two years. For the latest, I caught up with Joe Jimenez, the CEO of Novartis, one of the largest pharma companies and maker of the leading flu vaccine. Our interview follows, edited for clarity and length (Bartiromo, 2/17).